Crossmark

Sunvozertinib overcoming resistance to afatinib and osimertinib in lung adenocarcinoma harboring an EGFR exon 18 DelE709_T710insD mutation

Published Online: 2024-08-14

Authors

Ding, Kaibo

Peng, Zhongsheng

Liu, Dujiang

Xu, Yanjun http://orcid.org/0000-0001-7187-8804
Funding

Funding for this research was provided by:

Natural Science Foundation of Zhejiang Province (LTGY23H160007)
License Information

Text and Data Mining valid from 2024-08-14

Version of Record valid from 2024-08-14
More Information

Article History

Received: 31 May 2024

Accepted: 19 July 2024

First Online: 14 August 2024

Declarations

:

: Not applicable.

: The patient gave his written consent to this publication.

: The authors declare no conflicts of interest.

Document is current